Compare SONY & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SONY | PFE |
|---|---|---|
| Founded | 1946 | 1849 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.4B | 145.4B |
| IPO Year | 1958 | N/A |
| Metric | SONY | PFE |
|---|---|---|
| Price | $27.56 | $25.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 10 |
| Target Price | ★ $33.00 | $28.30 |
| AVG Volume (30 Days) | 3.9M | ★ 63.4M |
| Earning Date | 11-11-2025 | 11-04-2025 |
| Dividend Yield | 3.83% | ★ 6.79% |
| EPS Growth | 5.67 | ★ 131.89 |
| EPS | 1.31 | ★ 1.73 |
| Revenue | ★ $88,857,962,607.00 | $62,785,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.03 | N/A |
| P/E Ratio | $21.07 | ★ $14.67 |
| Revenue Growth | 3.02 | ★ 3.89 |
| 52 Week Low | $19.85 | $20.92 |
| 52 Week High | $30.34 | $27.69 |
| Indicator | SONY | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 35.62 | 51.94 |
| Support Level | $27.53 | $25.13 |
| Resistance Level | $27.82 | $26.19 |
| Average True Range (ATR) | 0.36 | 0.51 |
| MACD | -0.19 | -0.00 |
| Stochastic Oscillator | 2.48 | 61.26 |
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is the global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with five major business segments.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.